Agios Pharmaceuticals | AGIO - Ebitda



Agios Pharmaceuticals reported $-125797000 in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
AbbVie USD 4.4B 2.52B Mar/2025
Agios Pharmaceuticals USD -125797000 20.45M Jun/2025
Alnylam Pharmaceuticals USD 18.83M 13.65M Jun/2025
Amgen USD 3.6B 147M Jun/2025
Arrowhead Research USD -159327000 556.67M Jun/2025
Astellas Pharma JPY 140.34B 29.56B Jun/2025
AstraZeneca USD 4.96B 127M Jun/2025
Bayer EUR 236M 3.35B Jun/2025
Biogen USD 1.01B 456.5M Jun/2025
BioMarin Pharmaceutical USD 295.45M 49.49M Jun/2025
Bristol-Myers Squibb USD 3.27B 1.63B Jun/2025
Daiichi Sankyo JPY 101.6B 22.81B Mar/2025
Eli Lilly USD 7.5B 3.34B Jun/2025
Exelixis USD 220.92M 26.71M Jun/2025
Gilead Sciences USD 3.4B 797M Jun/2025
GlaxoSmithKline GBP 3.18B 45M Jun/2025
Incyte USD 581.52M 358.87M Jun/2025
Ionis Pharmaceuticals USD 150.23M 291.7M Jun/2025
Merck USD 7.74B 625M Mar/2025
Moderna USD -760000000 164M Jun/2025
Novartis USD 6.17B 339M Jun/2025
Novartis USD 6.08B 739M Jun/2025
Pfizer USD 5.32B 889M Jun/2025
Regeneron Pharmaceuticals USD 1.66B 926.5M Jun/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sarepta Therapeutics USD 126.42M 416.82M Jun/2025
Vertex Pharmaceuticals USD 1.34B 556.6M Jun/2025